Acceptability of Advanced Chronic Liver Disease Screening by Transient Elstography (Fibroscan ®) in Patients Hospitalised in Psychiatric Unit: a Single Center Prospective Study
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 180
- 试验地点
- 1
- 主要终点
- acceptability of non invasive assessement of liver fibrosis by Fibroscan in psychiatric patients
研究概览
简要总结
Scares data exists concerning the prevalence of chronic liver diseases in people with psychiatric disorders.
There are still many barriers to screening and linkage to care for patients having somatic illness.
Moreover follow-up of these patients may be difficult because of poor access to care, sometimes marginalization, and insufficient compliance with health programs.
The aim of this study is to asses acceptability of of advanced chronic liver disease screening by transient elstography (Fibroscan ®) in patients hospitalised in a psychiatric unit.
详细描述
Scares data exists concerning the prevalence of chronic liver diseases in people with psychiatric disorders.
There are still many barriers to screening and linkage to care for patients having somatic illness.
Moreover follow-up of these patients may be difficult because of poor access to care, sometimes marginalization, and insufficient compliance with health programs.
Transient elastography is a useful tool validated for early diagnosis advanced chronic liver disease.It is non-invasive, fast, and gives immediate results.
The aim of this study is to assess acceptability of of advanced chronic liver disease screening by transient elstography (Fibroscan ®) in patients hospitalised in psychiatric unit.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Prevention
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •adults ≥18 years
- •having a psychiatric condition and hospitalized in a psychiatry unit of CHU Montpellier , France
- •patients who lack capacity of consent if legal representative consents
- •involuntary psychiatric hospitalization, if consent is given
排除标准
- •lack of written consent
- •Unable to understand nature and objective of the methodology
- •Pregnant or breast feeding woman
- •Not affiliated with a French social security
研究组 & 干预措施
Psychiatric patient
All patients having psychiatric disorders and hospitalised in a Psychiatry Unit of CHU Montpellier will have an non invasive evaluation of liver fibrosis after giving their consent
干预措施: non invasive evaluation of liver fibrosis by transient elastography (Fibroscan ®) (Diagnostic Test)
结局指标
主要结局
acceptability of non invasive assessement of liver fibrosis by Fibroscan in psychiatric patients
时间窗: At Inclusion
Number of patient who have agreed to do fibroscan screening among patient to whom it was offered.
次要结局
- Prevalence of advanced liver disease in psychiatric patients(At inclusion)
- prevalence of excessive alcohol or drug consumption in psychiatric patients(At inclusion)
- correlation between advanced chronic liver diseases and risk factors for liver diseases in psychiatric patients(1 to 3 month after inclusion)
- assessment of referral to medical care when advanced fibrosis was diagnosed, regardless of its etiology(1 to 3 month after inclusion)
- prevalence of passed or active drug consumption (intraveinous, inhaled or sniffed) in psychiatric patients(At Inclusion)
- prevalence of viral hepatitis in psychiatric patients(At Inclusion)
- reason for refusal of non invasive evaluation of chronic liver disease(At Inclusion)